Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis

Current Opinion in Lipidology

Volumn 6, Issue 5, 1995, Pages 306-311

  Bruce, Can ^a   Tall, Alan R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID BINDING PROTEIN; LIPOPROTEIN; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL;

ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; GENETIC DISORDER; HUMAN; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN LIPID INTERACTION; REVIEW; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0029056060     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199510000-00010     Document Type: Review

References (47)

1. Glomset JA. The plasma lecithin : cholesterol ester acyltransferase reaction. J Lipid Res 1968, 9:155-167.
2. Lagrost L: Regulation of cholesteryl ester transfer protein (CETP) activity: review of in-vitro and in-vivo studies. Biochim Biophys Acta 1994, 1215:209-236.
3. Barter P, Rye KA: Cholesteryl ester transfer protein: its role in plasma lipid transport. Clin Exp Pharmacol Physiol 1994, 21:663-672.
4. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem 1995, 64 235-257.
5. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993, 364:73-75.
6. Tato F, Vega GL, Tall A, Grundy SM: Relationship between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb 1995, 15:112-120
7. Zhao SP, Smelt AH, van den Maagdenberg AM, van Tol A, Vroom TF, Gevers Leuven JA, van der Laarse A, van't Hooft FM. Plasma lipoprotein profiles of normocholesterolemic and hypercholesterolemic homozygotes for apolipoprotein E2(Arg158→Cys) compared. Clin Chem 1994, 40:1559-1566.
8. Kahri J, Syvanne M, Taskmen MR: Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 1994, 43:1498-1502.
9. Kushwaha RS, Reardon CA, Lewis DS, Qi Y, Rice KS, Getz GS, Carey KD, McGill HC Jr: Effect of dietary lipids on plasma activity and hepatic mRNA levels of cholesteryl ester transfer protein in high- and low-responding baboons (papio species). Metabolism 1994, 43:1006-1012.
10. Evans GF, Bensch WR, Apelgren LD, Bailey D, Kauffman RF, Bumol TF, Zuckerman SH: Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution. J Lipid Res 1994, 35:1634-1645.
11. Gaynor BJ, Sand T, Clark RW, Aiello RJ, Bamberger MJ, Moberly JB. Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition. Atherosclerosis 1994, 110:101-109.
12. Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A: Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994, 14:1581-1585.
13. Foger B, Wohlfarter T, Ritsch A, Lechleitner M, Miller CH, Dienstl A, Patsch JR: Kinetics of lipids, apolipoproteins, and cholesteryl ester transfer protein in plasma after a bicycle marathon. Metabolism 1994, 43:633-639.
14. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Rumsey SC, Deckelbaum RJ, Blaner WS, Ramakrishnan R: A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb 1994, 14:576-586.
15. Homma Y, Ozawa H, Kobayashi T, Yamaguchi H, Sakane H, Mikami Y, Mikami Y, Nakamura H: Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin : cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia. Atherosclerosis 1994, 106.191-201.
16. Foger B, Drexel H, Hopferwieser T, Miesenbock G, Ritsch A, Lechleitner M, Trobinger G, Patsch JR: Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia. Clin Investig 1994, 72:294-301.
17. Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y et al.: Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994, 94:1872-1882. This study establishes that genetic CETP deficiency is sufficiently common to influence HDL-cholesterol levels in the general Japanese population.
18. Inazu A, Koizumi J, Haraki T, Yagi T, Wakasugi T, Takegoshi T, Mabuchi H, Takeda R. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by intron 14 splicing defect in hyperalphalipoproteinemia. Hum Genet 1993, 91:13-16.
19. Akita H, Chiba H, Tsuchihashi K, Tsuji M, Kumagai M, Matsuno K, Kobayashi K: Cholesteryl ester transfer protein gene: two common mutations and their effect on plasma high-density lipoprotein cholesterol content. J Clin Endocrinol Metab 1994, 79:1615-1618.
20. Funke H, Wiebusch H, Fuer L, Muntoni S, Schulte H, Assman G: Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation 1994, 90.1-241.
21. Arai T, Yamashita S, Hirano K, Sakai N, Kotani K, Fujioka S, Nozaki S, Keno Y, Yamane M, Shinohara E et al.: Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994, 14:1129-1136.
22. Jiang XC, Moulin P, Quinet E, Goldberg IJ, Yacoub LK, Agellon LB, Compton D, Schnitzer-Polokoff R, Tall AR: Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem 1991, 266 4631-4639.
23. Bu X, Warden CH, Xia YR, de Meester C, Puppione DL, Teruya S, Lokensgard B, Daneshmand S, Brown J, Gray RJ et al.: Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum Genet 1994, 93:639-648. A marker locus linked to the CETP gene is linked to a locus determining HDL-cholesterol levels. However, the marker locus is 6 2 cM from the CETP locus and may be linked to another gene.
24. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R: Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994, 94:2377-2384. By using a polymorphism within the CETP gene, no association was found between the CETP locus and HDL-cholesterol levels. Because the sample population was a healthy one, abnormal CETP alleles may not have been present.
25. Tato F, Vega GL, Grundy SM: Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations. Arterioscler Thromb 1995, 15:446-451. Among low HDL-cholesterol patients, those with high levels of CETP have a lower incidence of heart disease than those with normal levels of CETP but abnormal lipoprotein lipase : hepatic lipase ratios.
26. Yamashita S, Hirano J, Ishigami M, Arai T, Sakai S, Nazaki S, Takemura K, Matsuzawa Y: Marked hyperalphalipoproteinemia (HALP) due to a combined reduction in cholesteryl ester transfer protein (CETP) and hepatic triglyceride lipase (HTGL) is accompanied by atherosclerotic cardiovascular disease (ACD). Circulation 1994, 90-1-510.
27. Hirano K, Yamashita S, Sakai N, Arai T, Yoshida Y, Nozaki S, Kameda-Takemura K, Matsuzawa Y: Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency. Ann NY Acad Sci 1995, 748:599-602.
28. Zhong S, Goldberg IJ. Bruce C, Rubin E, Breslow JL, Tall A: Human ApoA-II inhibits the hydrolysis of hdl triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest 1994, 94:2457-2467. This study demonstrates that apoA-II inhibits HDL remodeling by hepatic lipase. Thus, apoA-II may interfere with RCT, which is normally mediated by apoA-I and CETP.
29. Bruce C, Davidson WS, Kussie P, Lund-Katz S, Phillips MC, Ghosh R, Tall AR Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins. J Biol Chem 1995, 270:11532-11542. This in-vitro study shows that CETP binding to HDL is markedly influenced by particle size and shape and by lipid composition. The data suggest that CETP binds to nascent HDL with higher affinity than mature HDL.
30. Moulin P, Cheung MC, Bruce C, Zhong S, Cocke T, Richardson H, Tall AR: Gender effects on the distribution of the cholesteryl ester transfer protein in apolipoprotein A-I-defined lipoprotein subpopulations. J Lipid Res 1994, 35:793-802
31. Mown HO, Patsch JR, Ritsch A, Foger B, Brown S, Patsch W: High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin : cholesterol acyltransferase. J Lipid Res 1994, 35:291-300.
32. Duverger N, Rader D, Ikewaki K, Nishiwaki M, Sakamoto T, Ishikawa T, Nagano M, Nakamura H, Brewer HB: Characterization of high-density apolipoprotein particles A-I and A-I: A-II isolated from humans with cholesteryl ester transfer protein deficiency. Eur J Biochem 1995, 227:123-129.
33. Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Honuchi S, Matsuda I. Structural and functional differences of subspecies of ApoA-I containing lipoprotein in patients with plasma cholesteryl ester transfer deficiency. J Lipid Res 1995, 36:696-704. HDL from CETP-deficient patients are deficient in RCT. Both the capacity to remove cholesterol from macrophage foam cells and the cholesterol esterification rates are significantly lower in patients than in control individuals.
34. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, Friday KE, Rothblat C: A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994, 14:1056-1065.
35. Williams KJ, Tabas I: The response-to retention hypothesis of early atherogenesis. Athemscler Thromb 1995, 15:551-561
36. Chajek T, Aron L, Fielding CJ: Interaction of lecithin : cholesterol acyltransferase and cholesteryl ester transfer protein in the transport of cholesteryl ester into sphingomyelin liposomes. Biochemistry 1980, 19:3673-3677.
37. Agellon LB, Walsh A, Hayek T, Moulin P, Jiang XC, Shelanski SA, Breslow JL, Tall AR: Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 1991, 266:10796-10801.
38. Koizumi J, Mabuchi H, Yoshimura A, Michishita I, Takeda M, Itoh H, Sakai Y, Sakai T, Ueda K, Takeda R: Deficiency of serum cholesteryl ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 1985, 58:175-186
39. Yen FT, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW, Tall AR Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest 1989, 83:2018-2024.
40. Kunitake ST, Mendel CM, Hennessy LK: Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res 1992, 33: 1807-1816.
41. 2 from CETP-deficient patients are deficient in reverse cholesterol transport.
42. Pape ME, Rehberg EF, Marotti KR, Melchior GW: Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein. Inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoproteln levels. Arterioscler Thromb 1991, 11:1759-1771
43. Morton RE: Interaction of plasma-derived lipid transfer protein with macrophages in culture. J Lipid Res 1988, 29 1367-1377.
44. Ruiz-Noriega M, Silva-Cardenas I, Delgado-Coello B, Zentella-Dehesa A, Mas-Oliva J: Membrane bound CETP mediates the transfer of free cholesterol between lipoproteins and membranes. Biochem Biophys Res Commun 1994, 202:1322-1328.
45. Bialecki RA, Tulenko TN Acute exposure to cholesterol increases arterial nitroprusside- and endothelium-mediated relaxation. Am J Physiol 1993, 264:C32-C39.
46. Walter M, Kerber S, Fechtrup C, Seedorf U, Breithardt C, Assman G: Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency. Atherosclerosis 1994, 110:203-208.
47. Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall A: Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. dependence on natural flanking sequences. J Clin Invest 1992, 90:1290-1295.